## AON: Aon plc - XLF: Financial Services

### Executive Summary

No thesis match: MRS_10 -0.6% below STRENGTH zone (3.0-6.0%); PEG 1.58 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($345.99)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 6
- **Sentiment:** Neutral (Bullish: 1, Bearish: 0)

**1. OLD National Bancorp IN Purchases 16,268 Shares of Aon plc $AON**
- Source: MarketBeat | 20251224T112319 | Bullish | Relevance: 96%
- OLD National Bancorp IN significantly increased its stake in Aon plc by 346.6% in the third quarter, acquiring 16,268 additional shares to bring its total holdings to 20,961 shares valued at approximately $7.474 million. Aon exceeded Q3 expectations with EPS of $3.05 and revenue of $4.0 billion, leading to a consensus "Moderate Buy" rating from Wall Street analysts with a target price of $413.18. The company also pays a quarterly dividend of $0.745, and a substantial 86.14% of its shares are held by institutional investors.

**2. Brown & Brown’s Deal Spree Has Investors Asking About The Payoff**
- Source: Finimize | 20251224T140812 | Neutral | Relevance: 64%
- Brown & Brown Inc. (NYSE: BRO) has pursued an aggressive acquisition strategy, leading to record revenues but also increased debt and integration costs, causing its stock to underperform the S&P 500. While its M&A engine drives top-line growth, organic growth has slowed and its valuation trades at a premium compared to peers. Investors are monitoring the company's ability to manage debt, integrate acquisitions effectively, and deliver on earnings to justify its higher multiple.

**3. SiriusPoint announces expansion of IMG services following acquisition of Assist America**
- Source: FOX 2 | 20251224T120836 | Neutral | Relevance: 64%
- SiriusPoint's wholly-owned subsidiary, International Medical Group (IMG), has acquired Assist America, a leading provider of global emergency travel assistance services. This acquisition will significantly boost IMG's third-party medical and travel assistance revenue, enhance its U.S. presence, and expand its reach into Asia and the Middle East, offering substantial growth opportunities. The strategic move is expected to be accretive to both return on equity and earnings per share for SiriusPoint.

**4. Top Analyst Reports for Advanced Micro Devices, Goldman Sachs and Lam Research**
- Source: TradingView — Track All Markets | 20251226T180749 | Neutral | Relevance: 63%
- This article presents top analyst reports from Zacks Investment Research covering 16 major stocks, including Advanced Micro Devices (AMD), Goldman Sachs Group (GS), and Lam Research Corp. (LRCX), along with two micro-cap stocks, AstroNova, Inc. (ALOT) and Blue Dolphin Energy Co. (BDCO). It highlights an "Ahead of Wall Street" section for daily trading insights and provides full research report summaries for each featured company.

**5. Lawsuit: Ex-Brown & Brown execs hatched holiday plot to poach 200 workers**
- Source: Daytona Beach News-Journal | 20251225T104640 | Somewhat-Bearish | Relevance: 63%
- Brown & Brown Inc. has filed a lawsuit alleging that 29 former top employees conspired with British-based insurer Howden U.S. Services LLC to orchestrate a "mass employee raid," targeting 200 of its workers across multiple states. The lawsuit claims this move was strategically timed over the holidays "to inflict maximum competitive harm" and accuses the defendants of trade secret theft, contractual breaches, and unfair competition. This is not the first time Howden U.S. Services has been accused of poaching workers, with at least three other insurers filing similar lawsuits.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-16 | Mizuho | $389 | $0 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-16 | Mizuho | init | Neutral |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 2 ($0.00M) |
| Sells | 5 ($2.62M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 42.6% |
| Smart Money | **NEUTRAL** |
| Net Flow | 0.0% |
| Buying/Selling | 3 / 6 |

**Top Holders:**
- Vanguard Group Inc: 9.3% (-1.5%)
- Blackrock Inc.: 7.4% (-0.5%)
- Capital World Invest: 5.6% (-0.6%)
- State Street Corpora: 4.3% (+1.1%)
- Massachusetts Financ: 4.1% (-2.2%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- M&A activity or partnership announcements may unlock value.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 1.58 elevated, pricing in significant growth expectations. Quality metrics strong (ROE 38%, margin 16%). Balance sheet: $1.1B free cash flow. Insider selling cluster ($2.6M in 90 days), potential headwind.

| Metric | Value |
|--------|-------|
| Market Cap | $76.9B |
| Beta | 0.83 |
| 52W Range | $323.73 - $412.97 |
| Short Interest | 0.9% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.58 |
| Forward P/E | 18.7 |
| Current P/E | 21.0 |
| YoY Growth | 12.1% |
| EPS Direction | STABLE |

### Technicals

MRS_10 weakening modestly (-0.7% over 5 days). Below STRENGTH zone by 3.6pp (needs >3.0% for momentum thesis). MRS_5 turning positive (0.1%) - potential reversal signal. Below SMA200 (0.99x), long-term trend not supportive. MACD histogram positive (0.85), confirming momentum. RSI neutral at 60. OFD pattern: +SLL (Support).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -0.63% (CS: 58) | Neutral |
| RSI_14 | 59.5 | Neutral |
| MACD Histogram | 0.85 | Bullish |
| vs SMA20 | 1.019x | Above |
| vs SMA50 | 1.031x | Above |
| vs SMA200 | 0.991x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $356.87
- **Stop Loss:** $345.99 (3.0% risk)
- **Target:** $367.75 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 121
- **Position Value:** $43,181.27
- **Portfolio %:** 43.18%
- **Risk Dollars:** $1,320.00
- **Risk Per Trade:** 1.32%
- **Modifiers:** L1 110% | L2 120% | Combined 1.32x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.10x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with selective risk appetite amid holiday trading. VIX at extreme lows (13.6) signals complacency while positive yield curve (+59bps) and stable economic data support continuation. Focus on quality names with AI/infrastructure exposure while monitoring January volatility reset.*

### Earnings

**Next:** 2026-02-06 (Est: $4.77)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $2.91 | $3.05 | +4.7% |
| 2025Q2 | $3.41 | $3.49 | +2.5% |
| 2025Q1 | $6.04 | $5.67 | -6.1% |
| 2024Q4 | $4.25 | $4.42 | +4.0% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*